Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
May 28
Love0

Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report

By Chuck Lin No Comments
INTRODUCTIONCalcitonin gene-related peptide (CGRP) is a neuropeptide widely recognized for its role in vasodilation and neurogenic inflammation.1 In acne, CGRP receptors are found in sebaceous glands, where the peptide contributes…
Read More
May 28
Love0

On the Nod: A Scoping Review on Proposed Management Strategies for Erythema Nodosum

By Chuck Lin No Comments
INTRODUCTIONErythema nodosum (EN) is the most common form of panniculitis, classically presenting as tender, erythematous subcutaneous nodules on the extensor surfaces of the lower extremities. Systemic symptoms, including fevers, chills,…
Read More
May 28
Love0

Social Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONSocial media, particularly TikTok, may play a transformative role in promoting earlier hidradenitis suppurativa (HS) symptom recognition. Anecdotal reports suggest more patients seek medical evaluation after learning about HS symptoms…
Read More
May 16
Love0

Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors

By Chuck Lin No Comments
INTRODUCTIONPost-isotretinoin acne vulgaris relapse rates remain substantial, ranging from 20 to 60%.1 Given these high rates, guidelines for post-isotretinoin acne management (PIAM) are essential for maintaining treatment success and limiting…
Read More
May 16
Love0

An Analysis of Trends of United States Dermatology Clinician Workforce From 2016 to 2023: A Cross-Sectional Study

By Chuck Lin No Comments
INTRODUCTIONA shortage of United States (US) dermatologists exists. In 2023, US dermatologist density was 3.7 per 100,000, below the suggested 4 per 100,000.1 Geographic nonuniformity of dermatology clinicians amplifies this…
Read More
May 16
Love0

Considerations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin

By Chuck Lin No Comments
INTRODUCTIONWe read with interest the numerous recent publications regarding adverse dermatologic events related to glucagon-like peptide-1 receptor agonists (GLP-1RA).1,2,3 We hope to highlight some additional considerations related to the use…
Read More
May 12
Love0

A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis

By Chuck Lin No Comments
INTRODUCTIONDandruff is a common skin condition affecting up to half of the world’s population. Symptoms include pruritus, inflammation, and flaking. It is thought to be in part due to microbe…
Read More
May 09
Love0

Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study

By Chuck Lin No Comments
INTRODUCTIONIsotretinoin has been used to treat severe acne vulgaris since the early 1980s. Initial studies demonstrated acne improvement with dosing regimens of 0.1, 0.5, or 1.0 mg/kg daily.1,2 A decade…
Read More
May 05
Love0

Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares

By Chuck Lin No Comments
INTRODUCTIONSeborrheic dermatitis is a chronic inflammatory skin condition with an estimated global prevalence of 4.38%.1 The pathophysiology is not fully elucidated, though it involves lipid secretion by sebaceous glands, Malassezia…
Read More
Apr 30
Love0

Randomized-Controlled Trial Comparing Safety and Efficacy of Repairing Balm vs Topical Antimicrobial for Post-Procedural Wounds

By Chuck Lin No Comments
INTRODUCTIONActinic Keratosis And CryotherapyActinic keratosis (AK) is a concern worldwide and is associated with an increased risk of development of non-melanoma skin cancer.1 Chronic sun exposure plays a central role…
Read More
Apr 30
Love1

Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study

By Chuck Lin No Comments
INTRODUCTIONThe management of acne vulgaris is difficult owing to the chronic nature of the disease and frequent relapses.1 As such, treatment duration can last for months or years.1,2 Therapeutics that…
Read More
Apr 30
Love0

INDIVIDUAL ARTICLE: A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide (AP31)

By Chuck Lin No Comments
INTRODUCTIONPre-aging is a relatively new term used to describe the early, self-perceived signs of skin aging that occur in the 20s and early 30s.1 These early changes include dullness, loss…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months October 27, 2025
  • New Innovations of SkinCeuticals and Integrated Skincare October 23, 2025
  • Understanding Topical Steroid Withdrawal: Where Are We Now? October 23, 2025
  • Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis October 22, 2025
  • JDD Welcomes Our Newest Editorial Board Member October 21, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search